Andy Hadd

Andy Hadd

Company: Natera

Job title: Director of Regulatory Affairs


12.15 | 9.15 Power of Tumor-Informed and Personalized Assays to Drive High Sensitivity 12:15 pm

• Why personalized tumor-informed assays optimize sensitivity and specificity • Latest publications and data including IMvigor 010 • What clinical trial designs are possible with a personalized tumor-informed assayRead more

day: Day Three
